英文摘要 |
The influence of opioids on the composition and balance of gut microbiota have gained increased attention recently. These alterations, known as opioid-induced dysbiosis (OID), are correlated with multiple disease states and, also, the development of antinociceptive tolerance. Pre-clinical studies have recognized the importance of gut microbiome in the formation of analgesic tolerance and, therefore, make these commensals a new therapeutic subject for attenuating opioid tolerance and reducing opioid demands. In this article, we reviewed the infl uence of OID on the development of tolerance and the its potential role as a novel therapeutic target. |